The effect of smoking and sex on pharmacokinetics of clozapine and norclozapine

Wenxing Peng,Huande Li,Shuwu Xu
1997-01-01
Abstract:OBJECTIVE: To evaluate the influence of smoking and sex on the clinical pharmacokinetics of clozapine and its metabolite norclozapine after oral administration of fix dose (6 mg��kg-1) of clozapine to 30 schizophrenic patients (10 smokers, 20 non-smokers). METHODS: Plasma levels of clozapine and norclozapine were measured by HPLC. RESULTS: The halflife of elimination (t ( 1/4 )) was significantly longer in non-smokers than that in smokers [clozapine: (13.89 �� 3.15)h vs (9.22 �� 2.0)h; norclozapine: (13.68 �� 2.35)h vs (8.4 �� 2.74)h; P<0.05]. Peak plasma concentrations (c(max)) were higher in non-smokers than those in smokers [clozapine: (552.45 �� 186.41)ng��ml-1 vs (303.98 �� 118.65)ng��ml-1; norclozapine: (230.20 �� 86.18)ng��ml-1 vs (133.85 �� 62.42)ng��ml-1; P<0.05]. The plasma c(max) in female non-smokers was higher than that in male non-smokers, but no significant difference was noted statistically. CONCLUSION: Smoking accelerates metabolism of clozapine and norclozapine.
What problem does this paper attempt to address?